Global AI-Assisted Diagnosis in Neurology 麻豆原创 Growth (Status and Outlook) 2024-2030

Publication ID:

LPI10241530

Publication Date:

October 2, 2024

Pages:

Publisher:

LPI

Countries:

Global [1]

USD 3,660.00

Medical Devices [2]

Pharma & Healthcare [3]

Description:

The global AI-Assisted Diagnosis in Neurology market size was valued at US$ million in 2023. With growing demand in downstream market, the AI-Assisted Diagnosis in Neurology is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period.
The research report highlights the growth potential of the global AI-Assisted Diagnosis in Neurology market. AI-Assisted Diagnosis in Neurology are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of AI-Assisted Diagnosis in Neurology. 麻豆原创 players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the AI-Assisted Diagnosis in Neurology market.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Key Features:
The report on AI-Assisted Diagnosis in Neurology market reflects various aspects and provide valuable insights into the industry.
麻豆原创 Size and Growth: The research report provide an overview of the current size and growth of the AI-Assisted Diagnosis in Neurology market. It may include historical data, market segmentation by Type (e.g., Hardware, Software), and regional breakdowns.
麻豆原创 Drivers and Challenges: The report can identify and analyse the factors driving the growth of the AI-Assisted Diagnosis in Neurology market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the AI-Assisted Diagnosis in Neurology market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the AI-Assisted Diagnosis in Neurology industry. This include advancements in AI-Assisted Diagnosis in Neurology technology, AI-Assisted Diagnosis in Neurology new entrants, AI-Assisted Diagnosis in Neurology new investment, and other innovations that are shaping the future of AI-Assisted Diagnosis in Neurology.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the AI-Assisted Diagnosis in Neurology market. It includes factors influencing customer ' purchasing decisions, preferences for AI-Assisted Diagnosis in Neurology product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the AI-Assisted Diagnosis in Neurology market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting AI-Assisted Diagnosis in Neurology market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the AI-Assisted Diagnosis in Neurology market.
麻豆原创 Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the AI-Assisted Diagnosis in Neurology industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the AI-Assisted Diagnosis in Neurology market.
麻豆原创 Segmentation:
AI-Assisted Diagnosis in Neurology market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Segmentation by type
Hardware
Software
Segmentation by application
Visualization Analysis
Diagnoses
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
BioMind
Arterys
Brain Scientific
Methinks
Neuro-AI

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Scope of the Report
1.1 麻豆原创 Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 麻豆原创 Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 麻豆原创 Estimation Caveats
2 Executive Summary
2.1 World 麻豆原创 Overview
2.1.1 Global AI-Assisted Diagnosis in Neurology 麻豆原创 Size 2019-2030
2.1.2 AI-Assisted Diagnosis in Neurology 麻豆原创 Size CAGR by Region 2019 VS 2023 VS 2030
2.2 AI-Assisted Diagnosis in Neurology Segment by Type
2.2.1 Hardware
2.2.2 Software
2.3 AI-Assisted Diagnosis in Neurology 麻豆原创 Size by Type
2.3.1 AI-Assisted Diagnosis in Neurology 麻豆原创 Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global AI-Assisted Diagnosis in Neurology 麻豆原创 Size 麻豆原创 Share by Type (2019-2024)
2.4 AI-Assisted Diagnosis in Neurology Segment by Application
2.4.1 Visualization Analysis
2.4.2 Diagnoses
2.4.3 Others
2.5 AI-Assisted Diagnosis in Neurology 麻豆原创 Size by Application
2.5.1 AI-Assisted Diagnosis in Neurology 麻豆原创 Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global AI-Assisted Diagnosis in Neurology 麻豆原创 Size 麻豆原创 Share by Application (2019-2024)
3 AI-Assisted Diagnosis in Neurology 麻豆原创 Size by Player
3.1 AI-Assisted Diagnosis in Neurology 麻豆原创 Size 麻豆原创 Share by Players
3.1.1 Global AI-Assisted Diagnosis in Neurology Revenue by Players (2019-2024)
3.1.2 Global AI-Assisted Diagnosis in Neurology Revenue 麻豆原创 Share by Players (2019-2024)
3.2 Global AI-Assisted Diagnosis in Neurology Key Players Head office and Products Offered
3.3 麻豆原创 Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 AI-Assisted Diagnosis in Neurology by Regions
4.1 AI-Assisted Diagnosis in Neurology 麻豆原创 Size by Regions (2019-2024)
4.2 Americas AI-Assisted Diagnosis in Neurology 麻豆原创 Size Growth (2019-2024)
4.3 APAC AI-Assisted Diagnosis in Neurology 麻豆原创 Size Growth (2019-2024)
4.4 Europe AI-Assisted Diagnosis in Neurology 麻豆原创 Size Growth (2019-2024)
4.5 Middle East & Africa AI-Assisted Diagnosis in Neurology 麻豆原创 Size Growth (2019-2024)
5 Americas
5.1 Americas AI-Assisted Diagnosis in Neurology 麻豆原创 Size by Country (2019-2024)
5.2 Americas AI-Assisted Diagnosis in Neurology 麻豆原创 Size by Type (2019-2024)
5.3 Americas AI-Assisted Diagnosis in Neurology 麻豆原创 Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC AI-Assisted Diagnosis in Neurology 麻豆原创 Size by Region (2019-2024)
6.2 APAC AI-Assisted Diagnosis in Neurology 麻豆原创 Size by Type (2019-2024)
6.3 APAC AI-Assisted Diagnosis in Neurology 麻豆原创 Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe AI-Assisted Diagnosis in Neurology by Country (2019-2024)
7.2 Europe AI-Assisted Diagnosis in Neurology 麻豆原创 Size by Type (2019-2024)
7.3 Europe AI-Assisted Diagnosis in Neurology 麻豆原创 Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa AI-Assisted Diagnosis in Neurology by Region (2019-2024)
8.2 Middle East & Africa AI-Assisted Diagnosis in Neurology 麻豆原创 Size by Type (2019-2024)
8.3 Middle East & Africa AI-Assisted Diagnosis in Neurology 麻豆原创 Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 麻豆原创 Drivers, Challenges and Trends
9.1 麻豆原创 Drivers & Growth Opportunities
9.2 麻豆原创 Challenges & Risks
9.3 Industry Trends
10 Global AI-Assisted Diagnosis in Neurology 麻豆原创 Forecast
10.1 Global AI-Assisted Diagnosis in Neurology Forecast by Regions (2025-2030)
10.1.1 Global AI-Assisted Diagnosis in Neurology Forecast by Regions (2025-2030)
10.1.2 Americas AI-Assisted Diagnosis in Neurology Forecast
10.1.3 APAC AI-Assisted Diagnosis in Neurology Forecast
10.1.4 Europe AI-Assisted Diagnosis in Neurology Forecast
10.1.5 Middle East & Africa AI-Assisted Diagnosis in Neurology Forecast
10.2 Americas AI-Assisted Diagnosis in Neurology Forecast by Country (2025-2030)
10.2.1 United States AI-Assisted Diagnosis in Neurology 麻豆原创 Forecast
10.2.2 Canada AI-Assisted Diagnosis in Neurology 麻豆原创 Forecast
10.2.3 Mexico AI-Assisted Diagnosis in Neurology 麻豆原创 Forecast
10.2.4 Brazil AI-Assisted Diagnosis in Neurology 麻豆原创 Forecast
10.3 APAC AI-Assisted Diagnosis in Neurology Forecast by Region (2025-2030)
10.3.1 China AI-Assisted Diagnosis in Neurology 麻豆原创 Forecast
10.3.2 Japan AI-Assisted Diagnosis in Neurology 麻豆原创 Forecast
10.3.3 Korea AI-Assisted Diagnosis in Neurology 麻豆原创 Forecast
10.3.4 Southeast Asia AI-Assisted Diagnosis in Neurology 麻豆原创 Forecast
10.3.5 India AI-Assisted Diagnosis in Neurology 麻豆原创 Forecast
10.3.6 Australia AI-Assisted Diagnosis in Neurology 麻豆原创 Forecast
10.4 Europe AI-Assisted Diagnosis in Neurology Forecast by Country (2025-2030)
10.4.1 Germany AI-Assisted Diagnosis in Neurology 麻豆原创 Forecast
10.4.2 France AI-Assisted Diagnosis in Neurology 麻豆原创 Forecast
10.4.3 UK AI-Assisted Diagnosis in Neurology 麻豆原创 Forecast
10.4.4 Italy AI-Assisted Diagnosis in Neurology 麻豆原创 Forecast
10.4.5 Russia AI-Assisted Diagnosis in Neurology 麻豆原创 Forecast
10.5 Middle East & Africa AI-Assisted Diagnosis in Neurology Forecast by Region (2025-2030)
10.5.1 Egypt AI-Assisted Diagnosis in Neurology 麻豆原创 Forecast
10.5.2 South Africa AI-Assisted Diagnosis in Neurology 麻豆原创 Forecast
10.5.3 Israel AI-Assisted Diagnosis in Neurology 麻豆原创 Forecast
10.5.4 Turkey AI-Assisted Diagnosis in Neurology 麻豆原创 Forecast
10.5.5 GCC Countries AI-Assisted Diagnosis in Neurology 麻豆原创 Forecast
10.6 Global AI-Assisted Diagnosis in Neurology Forecast by Type (2025-2030)
10.7 Global AI-Assisted Diagnosis in Neurology Forecast by Application (2025-2030)

11 Key Players Analysis
11.1 BioMind
11.1.1 BioMind Company Information
11.1.2 BioMind AI-Assisted Diagnosis in Neurology Product Offered
11.1.3 BioMind AI-Assisted Diagnosis in Neurology Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.1.4 BioMind Main Business Overview
11.1.5 BioMind Latest Developments
11.2 Arterys
11.2.1 Arterys Company Information
11.2.2 Arterys AI-Assisted Diagnosis in Neurology Product Offered
11.2.3 Arterys AI-Assisted Diagnosis in Neurology Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.2.4 Arterys Main Business Overview
11.2.5 Arterys Latest Developments
11.3 Brain Scientific
11.3.1 Brain Scientific Company Information
11.3.2 Brain Scientific AI-Assisted Diagnosis in Neurology Product Offered
11.3.3 Brain Scientific AI-Assisted Diagnosis in Neurology Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.3.4 Brain Scientific Main Business Overview
11.3.5 Brain Scientific Latest Developments
11.4 Methinks
11.4.1 Methinks Company Information
11.4.2 Methinks AI-Assisted Diagnosis in Neurology Product Offered
11.4.3 Methinks AI-Assisted Diagnosis in Neurology Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.4.4 Methinks Main Business Overview
11.4.5 Methinks Latest Developments
11.5 Neuro-AI
11.5.1 Neuro-AI Company Information
11.5.2 Neuro-AI AI-Assisted Diagnosis in Neurology Product Offered
11.5.3 Neuro-AI AI-Assisted Diagnosis in Neurology Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.5.4 Neuro-AI Main Business Overview
11.5.5 Neuro-AI Latest Developments
12 Research Findings and Conclusion

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.